Skip to main content
Interoperability

HL7 v2 vs FHIR: Which Interoperability Standard Wins for Your Health System?

Stop chasing FHIR hype. For most health systems, HL7 v2 still rules high-throughput workflows. Here's a head-to-head on cost, speed, and security.

Ninety-six percent of U.S. non-federal acute care hospitals had adopted certified health IT by 2021 (ONC / HHS, Report to Congress). That's the good news. The bad news? Most of those systems still talk to each other using a standard born in 1987. HL7 Version 2 isn't sexy. It's not RESTful. But it's still the workhorse of healthcare interoperability. Meanwhile, FHIR—the modern, developer-friendly API standard—gets all the attention. Which one should your organization bet on? The answer isn't either/or. It's a deliberate, criteria-based decision.

Why This Comparison Matters Now

You've read the headlines: FHIR R5, published in March 2023, defines 157 resources (HL7 FHIR, Resource Index). US Core, based on FHIR R4, is the foundation for patient data access (US Core IG). But here's the uncomfortable truth: HL7 v2 is still used by more than 95% of U.S. healthcare organizations (HL7 International). That's not a legacy footnote—it's a fact of life. And with information blocking rules now enforced (ONC / HHS, Information Blocking), you can't afford to ignore either standard. You need to know exactly when to use each.

Criteria: Speed, Cost, Security, and Future-Proofing

Let's compare HL7 v2 and FHIR on four concrete criteria that matter to your IT budget and clinical workflows.

Criterion HL7 v2 FHIR
Throughput Optimized for high-volume, event-driven messaging; proven in labs and ADT feeds. RESTful API; easier for developers but can be slower for bulk transactions.
Implementation Cost Mature, widely understood; low barrier—most vendors support it out of the box. Newer, requires more design and mapping; higher upfront development time.
Security & Compliance Works fine under HIPAA Security Rule if you follow NIST SP 800-66 guidance. Same HIPAA obligations, but APIs add new attack surfaces; need robust access controls.
Future-Proofing Still evolving (v2.7 published in 2011), but not designed for modern web apps. Explicitly built for mobile, cloud, and patient access; aligns with TEFCA and USCDI.

When HL7 v2 Wins

If you're exchanging lab results, ADT (admission, discharge, transfer) messages, or orders between hospital systems, HL7 v2 is your champion. It's fast, reliable, and ubiquitous. Think about a busy hospital: every second counts. HL7 v2 handles thousands of messages per hour without breaking a sweat. It's the standard for high-throughput legacy workflows (HL7 International). For example, your lab system sends a result to your EHR—that's an HL7 v2 message. It's already working. Don't rip it out.

When FHIR Wins

FHIR shines when you need to expose data to third-party apps, patient portals, or population health tools. It's designed for developers: RESTful APIs, JSON, and discrete resources like Patient and Observation (HL7 International). If you're building a patient-facing app that needs to query a specific lab result, FHIR is the way to go. It's also the foundation for TEFCA, the nationwide framework for health information sharing (ONC / HHS, TEFCA). And with information blocking rules, you may be required to offer APIs. FHIR is built for that.

The Verdict: It Depends—But Start with v2

Here's my recommendation: Don't abandon HL7 v2. It's still the backbone of hospital interoperability. But start investing in FHIR for new, patient-centric use cases. Most organizations will run both in parallel for years. The real question isn't which standard is better—it's which one fits the job. For high-volume, real-time clinical messaging, HL7 v2 wins. For modern, API-driven data sharing, FHIR wins. If you're a small clinic, you might not need FHIR yet. If you're a large health system, you can't afford to ignore it.

Quick tip: Before you build a FHIR API, map your data to US Core profiles. It'll save you headaches later when you need to comply with TEFCA or information blocking rules.

Bottom Line

Stop treating this as a war. HL7 v2 and FHIR are complementary. Keep your v2 pipelines running for critical workflows, but start building FHIR APIs for patient access and innovation. The best move is to invest in a solid data governance strategy that supports both. That's how you'll win at interoperability.

Sources

  • ONC / HHS (Report to Congress) - https://healthit.gov/news/onc-outlines-health-it-interoperability-progress-report-congress/
  • HL7 International - https://www.hl7.org/fhir/
  • HL7 V2 Product Brief - https://www.hl7.org/implement/standards/product_brief.cfm?product_id=185
  • US Core Implementation Guide - https://hl7.org/fhir/us/core/
  • ONC / HHS (TEFCA) - https://www.healthit.gov/topic/interoperability/policy/trusted-exchange-framework-and-common-agreement-tefca

Share this article:

Comments (0)

No comments yet. Be the first to comment!